Avance Clinical is the largest full-service Australian CRO delivering quality clinical trials with globally accepted data in Australia and New Zealand for international biotechs.

Frost & Sullivan award

Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, has been providing CRO services in the region for the past 24 years.

The company’s clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services.

Pre-clinical through to Phase 1 and 2

Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phases 1 and 2 leveraging significant Government incentive rebates of 43.5% and rapid start-up regulatory processes.

With experience across more than 105 indications, the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.

Avance Clinical delivers customised solutions designed around specific client needs rather than a one size fits all approach.

Technology

As a company, Avance Clinical has focused on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.

Avance Clinical had its genesis in the University of South Australia in the early 1980s as the Centre for Pharmaceutical Research, when a group of academic scientists began providing clinical research and bioanalytical services to the local pharmaceutical industry.

Since then, it has grown to become the leading mid-sized CRO servicing the international drug development industry.

Avance Clinical offers some of the most extensive in-house clinical services including:

• ClinicReady – pre-clinical services
• Clinical Monitoring Management
• Data Management
• eClinical Solutions
• Safety and Pharmacovigilance
• Medical Writing
• Project Management
• Statistics and Pharmacokinetics
• Quality Assurance